WOLVERINE TRADING, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 199 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,655,667
+97642.6%
289,920
+17.1%
0.00%
-25.0%
Q1 2023$2,717
+293.8%
247,500
+55.0%
0.00%
+300.0%
Q4 2022$690
-100.0%
159,700
-53.1%
0.00%
-83.3%
Q1 2022$4,214,000
-43.0%
340,174
+4.8%
0.01%
-25.0%
Q4 2021$7,392,000
-6.3%
324,497
-5.4%
0.01%
-11.1%
Q3 2021$7,886,000343,0180.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 230,000$993,6001.92%
AlphaCentric Advisors LLC 352,500$1,522,8001.50%
NEA Management Company, LLC 3,969,834$17,149,6830.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 573,530$2,477,6500.76%
ARMISTICE CAPITAL, LLC 5,000,000$21,600,0000.38%
IRONWOOD INVESTMENT MANAGEMENT LLC 93,658$404,6030.27%
Artal Group S.A. 1,000,000$4,3200.24%
Virtus ETF Advisers LLC 64,786$279,8760.15%
TANG CAPITAL MANAGEMENT LLC 200,000$864,0000.13%
HighMark Wealth Management LLC 37,499$161,9960.12%
View complete list of AURINIA PHARMACEUTICALS INC shareholders